| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Med and Dev Officer | Chief Development Officer
1 company
Pizzuti Dana is a Chief Med and Dev Officer at CRNX. Recent filings cover 0 purchases and 21 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Pizzuti Dana a middling insider score of 56/100, based on 17 past trades. Over a 12-month horizon, 54.5% of those trades were profitable, with an average 12-month return of -7.1%.
Pizzuti Dana's largest disclosed position is in CRNX as Chief Med and Dev Officer, worth about $1.1M. The recent filings there lean toward selling, a net 178,891 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 14,375 | $44.87 | $645,006.25 | -33.5% | +17.5% | -32.6% | |
| Jun 24, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE | 9,500 | $45.73 | $434,435.00 | -25.5% | +10.4% | -32.2% | |
| Apr 15, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 14,375 | $44.47 | $639,256.25 | -34.1% | +23.9% | -32.1% | |
| Mar 20, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE | 15,089 | $44.06 | $664,763.41 | -35.2% | -2.6% | -24.5% | |
| Jan 3, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE10b5-1 | 14,375 | $35.00 | $503,125.00 | -70.9% | +31.6% | +47.5% | |
| Dec 21, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Med and Dev Officer | Sale+OE | 9,583 | $34.57 | $331,284.31 | -61.8% | +30.9% | +54.2% | |
| Apr 5, 2023 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Development Officer | Sell10b5-1 | 8,212 | $16.15 | $132,623.80 | -64.6% | +12.9% | +192.5% |